Spire Healthcare Group PLC

SPI

Equity

ISIN GB00BNLPYF73 / Valor 24881418

LSE London Stock Exchange, SETS (2025-10-20)

GBP 2.36-0.42%

Spire Healthcare Group PLC
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Spire Healthcare Group PLC, established in 2007 through the acquisition and rebranding of 25 Bupa hospitals, is a prominent independent healthcare provider in the United Kingdom. Listed on the London Stock Exchange and part of the FTSE 250, the company operates 38 hospitals and over 50 clinics, medical centres, and consulting rooms across England, Wales, and Scotland. Spire Healthcare offers a comprehensive range of services, including diagnostics, inpatient, day case, and outpatient care, with specialties in orthopaedics, gynaecology, cardiology, neurology, oncology, and general surgery. Additionally, the group provides private GP services, mental health, dermatological, and musculoskeletal care, and occupational health services to over 800 corporate clients. Notably, Spire is the leading independent provider of knee and hip operations by volume in the UK, underscoring its significant role in the healthcare sector.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Revenue increased by 11.2% year-on-year to £1,511.2 million, driven by a 5.5% growth in Hospitals and a significant 15.0% rise in Primary Care services. NHS revenue grew by 8.8%, while Private patient revenue saw a 4.3% uptick.

Adjusted EBITDA Improvement

Adjusted EBITDA rose by 11.1% to £260.0 million, reflecting price adjustments, higher acuity levels, and effective cost-saving measures. The adjusted EBITDA margin expanded to 17.2%, with Hospitals margin increasing by 30 basis points and Primary Care margin by 340 basis points.

Profitability and Earnings

Operating profit grew by 9.0% to £137.5 million on a stated basis. Adjusted profit before taxation saw a substantial increase of 29.4% to £50.2 million. However, profit after taxation slightly decreased by 6.8% to £26.0 million, and basic earnings per share fell by 7.4% to 6.3 pence.

Cost Savings and Efficiency

Cost savings accelerated, achieving over £20 million in FY24 through procurement standardisation, automation, and optimized staffing models. The company plans to further increase savings to at least £30 million in FY25, exceeding original targets.

Strategic Growth and Outlook

Spire Healthcare is expanding its Primary Care portfolio with three new clinics and expects mid-single digit revenue growth in FY25. The company remains confident in its strategic partnerships with the NHS and the growing demand for private medical insurance, aiming to deliver sustained profitability and efficiency improvements.

Summarized from source with an LLMView Source

Key figures

3.28%1Y

12.1%3Y

99.8%5Y

Performance

34.2%1Y

25.5%3Y

28.9%5Y

Volatility